Safety and efficacy of transitioning inflammatory bowel disease patients from intravenous to subcutaneous infliximab: a single-center real-world experience

por Jeffrey, Angus W., Abu-Rgeef, Reeham, Picardo, Sherman, Menon, Shankar, So, Kenji, Venugopal, Kannan
Publicado 2023